Seapointe College Disrupts the Norms of Education
August 19, 2023
MannKind Corporation finally gains U.S. Food and Drug Administration (FDA) approval for its inhaled insulin drug Affreza. The company has
MannKind corporation, the developer of the inhaled insulin Afrezza, suffered a minor drop in its shares as the FDA delayed
MannKind Corporation can breathe a little easier now that the U.S. Food and Drug Administration (FDA) has approved the drug
MannKind corporation will be facing an independent panel of experts and the U.S. Food and Drug Administration (FDA) on Tuesday,
